Biofil Chemicals & Pharmaceuticals Ltd

₹ 47.0 1.64%

11 Jul - close price

biofilgroup.net BSE: 524396 NSE: BIOFILCHEM

About

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd manufactures pharmaceutical bulk drugs^[1]

Key Points

Business Overview:^[1]^[2]
Company deals in manufacturing and trading of pharmaceutical and also manufactures plastic products required for packing pharmaceutical and other plastic products. Further, it also deals in providing job work facility in respect of manufacturing of pharmaceuticals drugs via 2 units viz. Pharmaceutical Division & Chemicals Division.

Website BSE NSE - BE

Market Cap ₹ 76.4 Cr.
Current Price ₹ 47.0
High / Low ₹ 92.0 / 40.4
Stock P/E 137
Book Value ₹ 11.5
Dividend Yield 0.00 %
ROCE 4.12 %
ROE 3.03 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company is expected to give good quarter

Cons

Stock is trading at 4.07 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 2.38% over past five years.
Company has a low return on equity of 3.43% over last 3 years.
Earnings include an other income of Rs.0.31 Cr.
Company has high debtors of 419 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	1.65	12.31	2.62	1.49	13.62	2.43	17.37	5.03	15.20	8.44	2.41	14.20	8.35
	1.51	11.94	2.46	1.26	13.21	2.01	17.13	4.84	15.24	8.13	2.29	13.89	8.24
Operating Profit	0.14	0.37	0.16	0.23	0.41	0.42	0.24	0.19	-0.04	0.31	0.12	0.31	0.11
OPM %	8.48%	3.01%	6.11%	15.44%	3.01%	17.28%	1.38%	3.78%	-0.26%	3.67%	4.98%	2.18%	1.32%
	0.03	0.02	0.02	0.02	0.03	0.02	0.03	0.03	0.41	0.03	0.02	0.02	0.24
Interest	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.02	0.01	0.01	0.01	0.01
Depreciation	0.12	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.08	0.10	0.10	0.10	0.08
Profit before tax	0.04	0.27	0.06	0.13	0.32	0.32	0.15	0.11	0.27	0.23	0.03	0.22	0.26
Tax %	200.00%	25.93%	33.33%	23.08%	34.38%	25.00%	20.00%	18.18%	11.11%	26.09%	33.33%	27.27%	23.08%
	-0.03	0.21	0.05	0.10	0.21	0.24	0.12	0.09	0.25	0.17	0.02	0.16	0.20
EPS in Rs	-0.02	0.13	0.03	0.06	0.13	0.15	0.07	0.06	0.15	0.10	0.01	0.10	0.12
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	7.17	5.86	13.17	13.45	12.36	23.13	29.69	35.75	22.38	30.04	40.04	33.40
	6.21	5.12	12.30	10.84	11.43	22.11	27.87	34.15	21.05	28.88	39.23	32.55
Operating Profit	0.96	0.74	0.87	2.61	0.93	1.02	1.82	1.60	1.33	1.16	0.81	0.85
OPM %	13.39%	12.63%	6.61%	19.41%	7.52%	4.41%	6.13%	4.48%	5.94%	3.86%	2.02%	2.54%
	0.06	0.46	0.53	0.14	0.10	0.10	0.17	0.80	0.15	0.10	0.49	0.31
Interest	0.15	0.21	0.15	0.16	0.15	0.16	0.12	0.07	0.04	0.04	0.04	0.04
Depreciation	0.22	0.25	0.26	0.28	0.30	0.37	0.41	0.41	0.43	0.43	0.40	0.38
Profit before tax	0.65	0.74	0.99	2.31	0.58	0.59	1.46	1.92	1.01	0.79	0.86	0.74
Tax %	20.00%	20.27%	20.20%	22.51%	20.69%	20.34%	17.81%	34.90%	31.68%	29.11%	17.44%	24.32%
	0.52	0.59	0.78	1.79	0.47	0.48	1.21	1.24	0.70	0.56	0.71	0.56
EPS in Rs	0.32	0.36	0.48	1.10	0.29	0.29	0.74	0.76	0.43	0.34	0.44	0.34
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	19%
5 Years:	2%
3 Years:	14%
TTM:	-17%

Compounded Profit Growth
10 Years:	-1%
5 Years:	-14%
3 Years:	-7%
TTM:	-21%

Stock Price CAGR
10 Years:	29%
5 Years:	26%
3 Years:	-5%
1 Year:	-28%

Return on Equity
10 Years:	6%
5 Years:	4%
3 Years:	3%
Last Year:	3%

Balance Sheet

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27
Reserves	-8.41	-7.86	-5.37	-3.58	-3.11	-2.62	-1.39	-0.14	0.56	1.03	1.93	2.51
	2.87	2.98	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44	0.47
	3.87	2.36	11.87	7.72	9.44	8.93	26.30	16.68	1.44	13.58	28.44	31.71
Total Liabilities	14.60	13.75	24.14	21.84	24.16	24.22	42.37	33.24	18.73	31.40	47.08	50.96
	9.17	9.06	8.98	9.16	9.25	10.29	10.09	9.78	9.42	9.00	8.62	8.34
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	5.43	4.69	15.16	12.68	14.91	13.93	32.28	23.46	9.31	22.40	38.46	42.62
Total Assets	14.60	13.75	24.14	21.84	24.16	24.22	42.37	33.24	18.73	31.40	47.08	50.96

Cash Flows

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	0.21	0.01	0.14	0.71	0.46	1.26	0.89	1.11	-0.22	-0.11	2.39	-1.92
	-0.24	-0.17	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10
	0.07	0.11	0.10	-0.11	-0.02	-0.08	-0.57	-0.83	-0.01	0.02	-0.12	0.00
Net Cash Flow	0.04	-0.05	0.05	0.13	0.06	-0.24	0.12	0.18	-0.30	-0.11	2.25	-2.03

Ratios

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	208.72	227.35	387.45	311.00	383.31	189.84	365.25	175.81	116.94	249.08	301.10	418.77
Inventory Days	20.53	15.99	3.46	7.29	38.11	21.73	24.37	48.85	24.20	16.11	24.81	39.53
Days Payable	276.79	198.49	400.98	304.52	341.46	156.66	373.80	178.39	11.25	168.39	268.08	366.78
Cash Conversion Cycle	-47.54	44.85	-10.07	13.76	79.95	54.90	15.82	46.27	129.88	96.80	57.83	91.52
Working Capital Days	70.25	137.65	86.47	126.46	150.90	76.69	70.32	68.51	132.76	110.57	73.38	119.23
ROCE %	7.66%	8.59%	9.64%	18.72%	5.06%	5.00%	10.08%	12.20%	6.20%	4.73%	4.94%	4.12%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.00%	0.00%	0.00%	0.00%
	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%
	53.10%	53.09%	53.10%	53.11%	53.10%	53.10%	53.11%	53.08%	53.11%	53.10%	53.11%	53.11%
No. of Shareholders	29,280	28,257	28,378	27,475	26,741	26,123	25,864	26,581	25,480	26,422	26,114	25,914

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.00%
	0.66%	0.66%	0.66%	0.66%	0.08%	0.08%	0.08%	0.08%	0.08%
	52.52%	52.52%	52.52%	52.52%	53.10%	53.10%	53.11%	53.08%	53.11%
No. of Shareholders	5,181	5,675	5,698	6,233	29,874	29,961	27,475	26,581	25,914

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports